Enlivex Therapeutics Ltd (ENLV)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
May 17, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Enlivex Therapeutics Shareholders Equity (Quarterly): 30.08M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.08M |
| September 30, 2023 | 38.78M |
| June 30, 2023 | 44.34M |
| March 31, 2023 | 50.57M |
| December 31, 2022 | 56.84M |
| September 30, 2022 | 63.27M |
| June 30, 2022 | 68.49M |
| March 31, 2022 | 77.65M |
| December 31, 2021 | 85.04M |
| September 30, 2021 | 88.08M |
| June 30, 2021 | 90.21M |
| March 31, 2021 | 90.60M |
| December 31, 2020 | 35.49M |
| September 30, 2020 | 28.50M |
| June 30, 2020 | 30.19M |
| March 31, 2020 | 32.06M |
| December 31, 2019 | 11.28M |
| September 30, 2019 | 13.78M |
| June 30, 2019 | 15.36M |
| Date | Value |
|---|---|
| March 31, 2019 | 13.46M |
| December 31, 2018 | 9.706M |
| June 30, 2018 | 1.56M |
| December 31, 2017 | 3.162M |
| September 30, 2017 | 3.746M |
| June 30, 2017 | 4.722M |
| March 31, 2017 | 6.268M |
| December 31, 2016 | 8.699M |
| September 30, 2016 | 11.37M |
| June 30, 2016 | 15.49M |
| March 31, 2016 | 20.18M |
| December 31, 2015 | 17.93M |
| September 30, 2015 | 22.11M |
| June 30, 2015 | 25.13M |
| March 31, 2015 | 28.10M |
| December 31, 2014 | 30.67M |
| September 30, 2014 | 33.39M |
| June 30, 2014 | 3.801M |
| December 31, 2013 | 0.175M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.28M
Minimum
Dec 2019
90.60M
Maximum
Mar 2021
50.03M
Average
44.34M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd | 65.56M |
| Pluri Inc | -0.356M |
| BioLine Rx Ltd | 13.22M |
| Can Fite Biofarma Ltd | 6.243M |
| BiomX Inc | 3.081M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.83M |
| Total Liabilities (Quarterly) | 6.747M |